Skip to main content
Pulike Biological Engineering,Inc. logo

Pulike Biological Engineering,Inc. — Investor Relations & Filings

Ticker · 603566 ISIN · CNE1000025N0 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,080 across all filing types
Latest filing 2018-06-07 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 603566

About Pulike Biological Engineering,Inc.

http://en.pulike.com.cn/

Pulike Biological Engineering, Inc. specializes in the research, development, and production of veterinary biological products and pharmaceutical preparations. The company focuses on animal disease prevention through the manufacture of high-end vaccines, diagnostic reagents, and veterinary medicines. Its product range primarily serves the swine and poultry sectors, featuring advanced biologicals such as genetically engineered vaccines and synthetic peptide products. Pulike maintains a strong emphasis on technological innovation, utilizing national-level research platforms to develop solutions for complex animal health challenges. The company’s core activities encompass the entire value chain from basic biotechnology research to the commercialization of veterinary health solutions, aiming to improve livestock productivity and biosecurity.

Recent filings

Filing Released Lang Actions
关于投资项目完成工商登记的公告
Capital/Financing Update Classification · 95% confidence The document is a company announcement regarding the completion of business registration for an investment project, specifically the establishment of a joint venture company. It includes details such as the company name, registration code, legal representative, registered capital, and business scope. There is no financial data, no mention of annual or quarterly reports, no audit information, no voting results, no management changes, and no earnings data. The document is a formal announcement about a corporate event related to investment and registration completion. This fits best under the category of Capital/Financing Update (CAP), as it relates to investment and capital activities of the company.
2018-06-07 Chinese
第三届董事会第十次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of a board meeting resolution by 普莱柯生物工程股份有限公司. It details the convening of the third board's tenth meeting, attendance, and the approval of a specific agenda item related to a technology development contract and related party transaction. There is no financial data, no mention of annual or quarterly reports, no earnings information, and no indication of a shareholder vote result. The content focuses on board decisions and meeting procedures, which fits the category of Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication but a substantive announcement of board decisions. Therefore, the classification is MANG with high confidence.
2018-06-04 Chinese
独立董事关于拟签订技术开发合同暨关联交易的独立意见
Regulatory Filings Classification · 95% confidence The document is an independent opinion from independent directors regarding a proposed technology development contract and related party transaction. It references regulatory rules and internal governance documents but does not contain financial statements or detailed financial data. The document is short (372 characters) and is a formal opinion on a specific transaction, not a full report or announcement of voting results. It fits best under Regulatory Filings (RNS) as it is a compliance-related disclosure that does not fit other categories.
2018-06-04 Chinese
关于拟签订技术开发合同暨关联交易的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding a proposed technology development contract and related party transaction involving the company 普莱柯生物工程股份有限公司. It details the transaction overview, parties involved, contract terms, pricing, and approvals by the board and independent directors. There is no financial statement or comprehensive financial report included. The document is a formal disclosure of a related party transaction and contract signing, typical of a regulatory announcement. It does not fit categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is not a report publication announcement since it contains substantive content about the transaction. The best fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2018-06-04 Chinese
2017年年度权益分派实施公告
Notice of Dividend Amount Classification · 100% confidence The document is an announcement regarding the implementation of the 2017 annual dividend distribution by 普莱柯生物工程股份有限公司. It details the dividend per share, relevant dates for dividend distribution, tax treatment for different shareholder categories, and contact information for inquiries. The document does not contain financial statements or comprehensive financial performance data but focuses solely on dividend amount and payment details. This matches the definition of a Notice of Dividend Amount (DIV), which announces dividend amounts, payment dates, and related shareholder details.
2018-05-29 Chinese
2017年年度股东大会的法律意见
Regulatory Filings Classification · 95% confidence The document is a legal opinion issued by a law firm regarding the legality and procedural compliance of the 2017 Annual General Meeting (AGM) of 普莱柯生物工程股份有限公司. It discusses the convening, attendance, voting procedures, and legality of the AGM but does not contain the actual AGM materials or presentations. The document is relatively short (3416 characters) and serves as a legal certification of the AGM process rather than the AGM materials themselves. Therefore, it is not the AGM Information (AGM-R) itself but a legal opinion related to the AGM. Given the nature of the document as a legal opinion on the AGM, it best fits under Regulatory Filings (RNS) as it is a compliance/legal document that does not fit other categories.
2018-05-21 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.